Form 4 for MRNA Moderna
Accepted 2026-02-25 00:00:00 ET · period of report 2026-02-23 · accession 0001682852-26-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-25 | 2026-02-23 | MRNA | Hoge Stephen | Pres | M - OptEx | $19.15 | +160.0K | 1.62M | +11% | +$3.06M |
| D | 2026-02-25 | 2026-02-23 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $48.84 | -160.0K | 1.46M | -10% | -$7.81M |
| DM | 2026-02-25 | 2026-02-23 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -160.0K | 111.7K | -59% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-23 | M | A | 111,679 | $19.15 | 1,569,106 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-23 | M | A | 48,330 | $19.15 | 1,617,436 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-23 | S | D | 160,009 | $48.84 | 1,457,427 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-02-23 | M | D | 48,330 | $0.00 | 48,330 | D | $19.15 · — to 2026-08-10 | 48,330 Common Stock | (F3) This option is fully vested and exercisable. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-02-23 | M | D | 111,679 | $0.00 | 111,678 | D | $19.15 · — to 2026-08-10 | 111,679 Common Stock | (F3) This option is fully vested and exercisable. |